This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.
Soumitra (Sam) Deka

Soumitra (Sam) Deka

Counsel

Silicon Valley
T: +1 212 836 7211
F: +1 212 836 6547


icon Download vCard

Legal Services

Education

  • Temple University School of Law
    JD, 2003
  • Tulane University
    BS, Physics, 2000

Bar Admission(s)

  • New York
  • California
  • US Court of Appeals for the Federal Circuit
  • US Court of Appeals for the Second Circuit
  • US District Court for the District of Colorado
  • US District Court for the Eastern District of New York
  • US District Court for the Eastern District of Wisconsin
  • US District Court for the Southern District of New York
  • US Patent and Trademark Office

Sam Deka focuses primarily on patent litigation trials and appeals. He is a registered patent attorney licensed to practice before the U.S. Patent and Trademark Office. He also regularly counsels clients on transactional matters involving intellectual property.

Mr. Deka has worked on patent cases involving a wide range of technologies, from semiconductors, optical networking components, and 3-D display technology, to pharmaceuticals, including Viagra and Celebrex.

Prior to joining Kaye Scholer, Mr. Deka was a summer associate and associate at Kenyon & Kenyon LLP. While in law school, he also worked for the chief in-house intellectual property counsel of a semiconductor design and manufacturing company. While in college, Mr. Deka gained technical research experience on optical networking technologies as an intern at Bell Labs. 

Representative Matters

  • Cephalon, Inc. v. Fresenius KABI USA, LLC, 15-cv-00536 (D. Del.).   Counsel for Cephalon in a patent infringement case involving Cephalon’s drug Treanda (bendamustine hydrochloride). 
  • Acorda Therapeutics Inc. v. Actavis et al., 1:14-cv-00882-LPS (D. Del.). Counsel for Acorda Therapeutics in a set of patent infringement cases involving Acorda’s drug AMPYRA (dalfampridine), an oral medication to improve walking in people with multiple sclerosis (MS).
  • Pfizer Inc. v. Lupin Pharma et al., 2:13-cv-121 (E.D. Va.). Counsel for Pfizer in a patent infringement case involving Pfizer’s drug Celebrex (celecoxib).
  • Genetic Technologies LTD v. Pfizer Inc., 12-cv-00395 (D. Del.). Counsel for Pfizer in defense of a patent infringement action relating to methods of DNA analysis and gene mapping.
  • Tomita Technologies Int’l Inc. v. Nintendo Co., Ltd., 1:11-cv-04256-JSR (S.D.N.Y.). Counsel for Nintendo in a patent infringement case involving stereoscopic (3-D) image capture and display technology.
  • Pfizer Inc v. Teva Pharmaceuticals USA, Inc. et al., 2:10-cv-128 (E.D.Va.).  Counsel for Pfizer in a patent infringement case involving Pfizer’s drug Viagra (sildenafil).
  • QinetiQ Limited v. Oclaro, Inc., 4:10-cv-00080-SBA (N.D.Ca.). Counsel for QinetiQ in a patent infringement case involving QinetiQ’s patents on multi-mode interference (MMI) waveguides, Mach-Zehnder interferometers, and related optical telecommunications technologies.